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Investigation of chemical exposures as possible etiologic factors for breast cancer has not been a research priority in the United States, which is sur-
prising given the evidence from animal studies that environmental chemicals cause cancer and reproductive dysfunction. Study of environmental
chemicals has also been indicated by the failure of traditional epidemiologic methods to account for significant proportions of breast cancer inci-
dence with other risk factors. The fact that breast cancer risk is strongly associated with reproductive hormones is a further clue that environmental
chemicals should be investigated. In addition to cancer, specific outcomes that need to be explored are reproductive dysfunction, immunotoxicity
and neurotoxicity. Policy guiding our research should encourage toxicologic investigations of exposures to environmental chemicals that use state-
of-the-art methods to determine exposure and human health effects. Using the approach suggested by John McLachlan, functional toxicology
should be used to assess the activity of chemicals with regard to these outcomes. Just as dioxin toxicity can be expressed as toxic equivalents,
estrogenic activity, for example, can be characterized in terms of estrogenic equivalents. In addition to the need to undertake this kind of research,
needs for methods development and creative research funding mechanisms are discussed. Prevention of breast cancer may require intervention at
an early age. Better understanding of breast cancer etiology, and especially its environmental components, may lead us toward that goal. - Environ
Health Perspect 103(Suppl 6):87-91 (1995)
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Pesticides such as DDT have been regu-
lated in the United States for more than
two decades. The ban of DDT followed
observation of adverse reproductive effects
in wildlife along with evidence of carcino-
genicity in animals and biological persis-
tence in animals and humans. DDT
belongs to a class of organochlorines that
includes a number of other pesticides-
chlordane, hexachlorobenzene, benzene
hexachloride (aka lindane), for example-
and halogenated biphenyls (polychlorinated
biphenyls or PCBs). Many organochlorines,
including DDT and PCBs, were banned in
the 1970s. Chlordane was regulated more
recently, and lindane remains in limited
pharmaceutical use.
In some ways, the policy to ban
organochlorines has worked. From the
U.S. Environmental Protection Agency's
(U.S. EPA) National Human Adipose
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Tissue monitoring program, data clearly
show that levels of DDT in adipose tissue
in the U.S. population have steadily
declined since 1972 (Figure 1) (1). PCB
levels are also going down, albeit more
slowly (2). In addition, control of DDT
established a precedent that has probably
facilitated regulation of other organochlo-
rine pesticides (e.g., chlordane) and persis-
tent halogenated hydrocarbons. An example
would be polybrominated biphenyls (PBBs)
that were used as a fire retardant until a dis-
astrous contamination of cattle feed in
Michigan in 1973 and 1974. Control of
pesticide usage has also stimulated a search
for less toxic, more readily biodegradable
pesticides. Registration ofpesticides is now
mandatory for new products, which must
satisfy requirements ofsafety and toxicity.
An unfortunate consequence ofregula-
tory policy is that policymakers may take
the view that banning solves the problem. It
seems obvious that the efficacy ofregulatory
policy should be supported by scientific
evaluation and systematic followup. Thus,
with DDT, potential for exposure still
exists even 20 years after its ban, and
organochlorines continue to pervade the
environment. Regulation may have halted
deliberate discharge into the ecosystem in
the United Sates, but its continued use in
developing countries allows DDT to cross
international borders in food produce and
in the air and water. Only recently has the
United States decided to restrict exports of
a number ofpesticides including DDT (3).
Continuing environmental contamina-
tion by organochlorines has resulted in sus-
tained low-level exposure among wildlife
and concomitant reproductive dysfunction
(4). Body burdens of DDT in humans are
still significant in the United States and
worldwide. International studies frequently
report detectable levels of DDT residues,
with special concern directed toward those
ubiquitous levels in human milk that often
exceed exposure guidelines recommended
to protect against cancer (5). Human milk
is now the major source ofinfant exposure
to DDT in the United States. Ironically
lactation is the most efficient means of
reducing a woman's body burden of
organochlorines.
Status of Research on DDT
and Human Health Effects
After 1972, little further attention was paid
to research directed specifically to identify
human health effects from DDT. This
complacent attitude may be attributed to
the absence of overt, prominent human
health effects due to DDT exposure, in
spite ofoverwhelming evidence of tumori-
genicity and reproductive failure in
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Figure 1. Levels of DDT in adipose tissue in the U.S.
population. Data from Kutz et al. (1).
animals. Indeed some researchers con-
cluded that DDTwas quite safe forhumans.
In view ofthe extensive animal data on
reproductive dysfunction, the scientific lit-
erature has remarkably few studies on
human reproduction related to DDT expo-
sure. Moreover, existing studies are limited
with respect to numbers ofsubjects as well
as overall design sophistication. Only four
human reproductive studies are cited by
IARC, two focusing on prenatal effects and
two on preterm abortion (6).
Attempts to determine cancer risk asso-
ciated with DDT exposure have been
somewhat more extensive, but the data are
nevertheless quite inconclusive. Human
studies have looked for elevated rates of
any kind of cancer death among industri-
ally exposed persons. Some have focused
on potential risks for lung cancer, liver can-
cer, lymphoma, soft-tissue sarcoma, and
leukemia in case-control studies. However,
few ofthese studies had adequate exposure
assessment, which lessens the power to
detect an effect. In many reports, there
were no adequate controls for exposures
other than DDT, and most studies did not
start out specifically to investigate DDT
cancer risk (6). Nevertheless, hematopoi-
etic cancer and lung cancer risk continues
to be weakly associated with DDT expo-
sure estimates in more recent studies.
As a result, existing research efforts
have led to the conclusion that DDT is a
possible human carcinogen, although it is
designated as carcinogenic to animals (6).
Evidence for reproductive toxicity is con-
sidered scant, whereas in animals clear
impairment is recognized. An exception is
the reported observation in 1986 that sug-
gested a hormonal effect ofDDT; this was
the finding that women with higher body
burdens ofDDE reported shorter duration
of lactation (7). A second study recently
confirmed these findings (8). This research
originated at the National Institute of
Environmental Health Sciences (NIEHS),
an agency whose intramural program has
supported an innovative approach to
human exposure and to experimental stud-
ies on hormonally active substances.
Indeed, since these were the first strong
human data of the kind, the observation
relating high DDE levels to curtailed lacta-
tion led us to examine the relationship of
persistent organochlorines to breast cancer
risk that will be described below.
In view ofthis evidence, the policy that
banned DDT has failed to influence our
national research agenda. Not enough
effort has been made to target environmen-
tal research in the area of hormonally
related cancers. To some extent, this failure
is now being redressed by current
NIEHS/NCI (National Cancer Institute)
initiatives. In defense ofcurrent policy, it
could be said that animal carcinogenicity
studies on organochlorines led researchers
to look at the wrong outcomes, because
these relatively high-dose studies found
mainly liver tumors, a relatively rare tumor
in humans in the United States. However,
the animal data also indicate that organo-
chlorines are estrogenic and may be tumor
promoters, and therefore specific study
designs should have been investigated to
assess this role for DDT and comparable
organochlorines in both animals and
humans. (One such report exists in the ani-
mal literature.) No particular attention has
yet been paid to the potential environmen-
tal link with ovarian, colon, endometrial,
testicular, prostate, and breast cancer. In
view of the unexplained risk and rising
rates for breast cancer and prostate cancer,
environmental etiology for these tumors is
an important line of research that should
be vigorously pursued.
Environmental links to cancer immedi-
ately afford a means of prevention. The
failure to make this a research priority has
been criticized in characterizing the narrow
approach to cancer research since declara-
tion of the war on cancer (9). These past
20 years have seen an increase, rather than a
reduction, in overall cancer rates. Critics
maintain that our national approach has
"neglected research aimed at prevention in
favor of the search for cures" (10). Even
among those researchers who subscribe to
the environmental thesis, many maintain
that increased rates ofcancer can be attrib-
uted to diet and smoking and not industrial
carcinogens. Meanwhile, environmental
areas that have been explored as means of
cancer prevention include viruses, vitamins,
diet, tamoxifen, smoking, occupational
exposures, radiation, but not pollution or
ambient chemical exposures (10).
Breast Cancer and DDT
Breast cancer research has been cited as an
example of setting poor research priorities
in that no attempts were made to pursue a
connection between cancer and exposure
to carcinogenic chemicals in the food
chain, even in the context of an otherwise
enormous investment in studying links
between diet and cancer (10). There were
five studies on breast cancer and DDT
exposure before 1985, and only one of
these was in the United States. Yet, other
risk factors have not been able to fully
explain the dramatic increase in breast can-
cer rates in the United Sates during 1970
to 1990, and only some of the increase is
attributable to enhanced screening.
Environmental factors have long been
invoked as an explanation for breast
cancer, but environmental chemicals per se
have not been widely accepted as risk fac-
tors for breast cancer. Rather, epidemio-
logic studies have implicated the diet,
alcohol consumption, drug use, and radia-
tion as risk factors for breast cancer that
might account for the environmental evi-
dence. Unfortunately, the identification of
these risk factors has not gone very far in
providing us with an explanation for a
major proportion of breast cancer inci-
dence nor have these studies given us much
hope for preventing a significant amount
of the disease. Investigation of chemical
exposures as possible etiologic factors for
breast cancer has not been a priority, which
is surprising given the several animal mod-
els that use chemical carcinogens [e.g.,
polycyclic aromatic hydrocarbons (PAH),
methylnitrosourea (MNU)].
In the past few years, evidence has
emerged that supports a possible relation-
ship between breast cancer and exposure to
organochlorines in the environment,
whence exposure occurs predominantly
through the diet. There have been four
recent case-control studies linking envi-
ronmental organochlorine exposures to
breast cancer risk (Table 1). The relative
risks reported in these studies are in the
range of 2 to 10. If the data are confirmed
in future research, these will rank among
the higher risks observed for breast cancer
in the epidemiologic literature. However,
the studies were relatively small and require
extensive confirmation before this associa-
tion becomes an established risk factor for
breast cancer.
In the late 1980s, the first ofthese stud-
ies in Connecticut found approximately
50% higher levels of DDE [bis(4-
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Table 1. Recent case-control studies of breast cancer and DDT exposure.
References Cases Controls Relative risk
Mussalo-Rauhamaa et al. (16) 44 33 a(correlation DDE-ER)
Falck et al. (12) 20 20 -3 (67>33 percentile)
Wolff et al. (13) 58 171 -4(10-90 percentile)
Dewailly et al. (14) 18 17 ER+: -9(67>33 percentile)
"Relative risk of 10 for highest BHC (hexachlorocyclohexane) exposures.
chlorophenyl)-1,1dichloroethene]*, DDT
[bis(4-chlorophenyl)-- ,1,1-trichloroethane],
and higher chlorinated PCBs in mammary
adipose among 20 breast cancer cases com-
pared with 20 controls (11). The risk for
DDT was not statistically significant. There
was approximately a 3-fold increased riskfor
the highest versus the lowest tertile ofthese
chemicals in adipose tissue.
A second study took advantage of a
well-designed nested case-control study in
which blood had been collected before
diagnosis ofbreast cancer (12). Again, lev-
els of DDE and PCBs in serum were
higher among breast cancer cases than
among carefully matched controls, but
only differences for DDE were statistically
significant. Women with the highest levels
of DDE (upper 10%) had about a 4-fold
increased risk compared with levels in the
lowest 10%. There was approximately a
9% increased risk for every one part per
billion (ppb) ofDDE in blood serum.
Quite recently, a Canadian study found
significantly higher levels ofDDE in estro-
gen receptor-positive (ER) breast cancer
cases compared with ER-negative cases and
with controls (13). For ER-positive breast
cancer, the relative risk was approximately
9 for the highest versus the lowest tertile of
these chemicals in adipose tissue. In sup-
port of this evidence, H. Mussalo-
Rauhamaa (14) has more recently reported
a correlation between DDE levels and ER
levels in their patients, although the find-
ings require cautious interpretation since
no age adjustment was made.
Similar relative risks for breast cancer
were found among the Finnish women
with elevated levels ofP-hexachlorocyclo-
hexane, a lindane-related residue, although
no association was found with other
organochlorines including DDE (15). The
relative risks in these four studies are in the
same range as those estimated from the
animal data (16,17). The potential associa-
tion with ER status is of some interest,
given the estrogenic activity of DDT and
the rising rates of ER-positive cancer
among olderwomen (18).
Since DDT levels in the U.S. popula-
tion are gradually receding, this trend
should accompany reduced risk ofany dis-
ease associated with DDT exposures in the
United States. However, DDT and other
organochlorines are still widely used in
developing countries where it may affect
public health or it may cross international
borders. Furthermore, besides DDT there
are myriad other potentially estrogenic
chemicals in commerce that require our
vigilance (4,19). Many ofthese new chem-
icals are not detectable long after exposure,
e.g., atrazine and methoxychlor.
Future Research Priorities
How can our scientific research establish-
ment be more effective in protecting
human health? Whether or not the DDT-
breast cancer link is confirmed, these find-
ings have great potential for teaching us
more about breast cancer etiology and in
leading us toward preventive strategies.
Several lines of research can be suggested.
In addition to the potential for prevention,
much can be learned about etiology by
understanding environmental contributions
to breast cancer (Table 2).
ResearchAreas toEmphasize in
Environmental Research
Recent work on breast cancer, as well as
accumulating evidence about reproductive
failure in animals, should encourage vigor-
ous exploration ofchemical factors in the
environment. Cancer, reproductive dys-
function, and neurotoxicity need to be
investigated. One prominent researcher in
the field of environmental estrogens has
recently suggested that we should design
our research using functional toxicology,
i.e., research that defines chemicals more
by their function than by their chemistry
(20). One such area of toxicology that
merits research attention in both basic
science and epidemiology is reproductive
dysfunction by environmental chemicals
(e.g., estrogenicity or endocrine disrup-
tion). In a similar context, toxic equivalent
Table 2. Research priorities in human environmental
toxicology.
Cancer, reproductive dysfunction, neurotoxicity
Functional toxicology: relative toxicity using equivalents
* Dioxin toxic equivalency(TED)
* Estrogenicity (EEQ?)
* Neurotoxicity (NEQ?)
Methods for epidemiology and statistics
* Studydesign strategies
* Data analysis techniques
Methods for exposure assessment
* Individual biological markers
* Markers/indices for short-lived chemical exposures
Funding mechanisms
* Solicited proposals by NIH fortesting unusual
hypotheses
* Special review process
(TEQ) factors have been developed for
dioxin-like activity, which may also parallel
antiestrogenic activity (21). From the
available literature, it is possible to con-
struct estrogenicity or endocrine equiva-
lents (EEQ?) that might be useful in terms
ofrelative biological activity for regulatory
purposes (22,23). This database can be
easily expanded to include a wide range of
environmental contaminants.
Functional toxicology also touches a
further field that is ofpotentially great rele-
vance to breast carcinogenesis, i.e. the rela-
tionship between P450 activity and
exposures to DDT and other organochlo-
rines. Association ofelevated P450 activity
with DDT and PCB exposure in humans
has been known for many years (24,25).
Organochlorines have been widely studied
for their ability to induce P450 enzymes
whose baseline activity is genetically deter-
mined. The cytochrome P450 enzymes are
responsible for metabolizing endogenous,
as well as exogenous, chemicals in the body
(e.g., estrogen and PAH). Certain ofthese
metabolites may act as ultimate carcino-
gens that bind directly to DNA and cause
mutations. The genes for P450 are poly-
morphic in humans, and the distributions
ofthe polymorphisms vary between differ-
ent ethnic populations. Hormones are also
metabolized by these enzymes. However,
while the P450 enzymes have been widely
studied, only recently has this area begun
to reach fruition in the study of human
cancer (26). Although no information is
currently available on breast cancer, a
number ofinvestigations on breast cancer
are now underway.
MethodsDevelopmentNeeds
Research priority should be placed upon
improving methods for exposure assessment
and into developing innovative epidemio-
Volume 103, Supplement 6, September 1995
*DDE is the major residue of DDT in the environ-
ment, and it is usually found in humans at higher
levels and more frequently than any other organo-
chlorine.
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logic and statistical methodologies for
study design and analysis. Better epidemio-
logic tools and improved quantitation will
allow us to design epidemiologic studies to
trace putative carcinogenic pathways.
Other endpoints besides cancer are impor-
tant to study as well. Reproductive and
neurotoxic effects may be important risk
outcomes to consider.
Existing methodologies are often inade-
quate to study complex diseases like cancer,
reproductive dysfunction, and neurotoxic-
ity, especially when attempting to link sub-
tle biological effects with complex and
low-level exposures. Therefore, research
testing ofenvironmental hypotheses would
be greatly facilitated by the availability of
better epidemiologic instruments and
sophisticated statistical techniques.
Improved methods would enable us to
more adequately evaluate associations
between indicators ofpreclinical disease,
genetic factors, causal agents, and risk.
Techniques are needed for exposure
assessment that will provide quantitative
individual measurements. These tech-
niques must be able to detect very low lev-
els of exposure that are common in
environmental circumstances. Internal bio-
logical markers ofexposure and disease are
usually more sensitive and specific than
estimates using external methods (i.e., air
pollution or water contamination levels).
This may be useful for DDT, where cumu-
lative body burdens persist for many years,
reflecting integrated past exposure.
However, many of the newly developed
pesticides that have replaced organochlo-
rines are not persistent, presenting a diffi-
cult problem in exposure assessment. With
respect to cancer risk, exposure assessment
is even more difficult because initiating
events may have taken place 10 to 30 years
before cancer diagnosis. Similarly, PAH
and nitro compounds are potential etio-
logic agents for cancer and are not persis-
tent in the body. For this reason, historical
exposure information has often been used;
this is another means ofexternal exposure
assessment methods.
FundingMechanisms
Our scientific research and funding strate-
gies must allow more creative ideas to be
tested. En route to soliciting and establish-
ing new methodology and to confirming
and extending our research on DDT and
breast cancer, it may be necessary to fine-
tune our research review and funding poli-
cies. Traditional funding mechanisms
possess a certain rigidity toward new,
unconventional ideas. The National
Institutes ofHealth (NIH) likes to fund a
sure thing. As a result, it is a constant
struggle to eke out support appropriate
funding mechanisms for new, untested
ideas, especially in the current climate of
tight funding. Multiple reviews or special
screening panels for special projects might
be considered. The Request forApplication
(RFA) mechanism may also be suitable for
circumventing the entrenched review
process and for encouraging scientific
flights offancy. Recently NCI and NIEHS
have issued RFAs that will allow
researchers to confirm and expand these
findings. Criticism has been leveled at the
U.S. EPAon another front-that ofwhether
a regulatory agency can successfully under-
take and administer a research program
(27). Since the U.S. EPA's budget is a sig-
nificant proportion offunding for environ-
mental research, its record ofperformance
in predicting as well as preventing environ-
mental disease may be a starting point for
examining the structure ofthis agency.
Relevance to Environmental
Health Effects among Children
The example of breast cancer relates to
children's environmental health, especially
with respect to the potential for prevention
ofexposures. Evidence in animals demon-
strates that developing tissues are more sen-
sitive to carcinogenic exposures. Recent
evidence, though limited, suggests that
exposure to cigarette exposure or alcohol at
an early age may be associated with
increased risk for breast cancer among
young women. Women in the United
States have markedly higher age-specific
rates of breast cancer compared with
Japanese women, and the differences are
most dramatic among premenopausal
women. Part of the difference may be
dietary or environmental factors that alter
the onset ofpuberty, which occurs much
later in Japanese women. Therefore pre-
ventive measures such as dietary interven-
tion may need to be undertaken at an early
age. Prevention of environmental expo-
sures related to breast cancer is also be an
important potential means of prevention
that should be vigorously pursued.
Rates ofbreast cancer occurrence in the
United States have steadily risen since
1940. During that same period, levels of
pesticide and PCB residues in human adi-
pose tissue in the United States have
shown parallel increase, following their
introduction into commerce around the
time ofWorld War II. Since then, despite
much research on the question, only three
factors have been generally agreed to be
strongly linked to breast cancer: age, coun-
try ofbirth, and family history. These fac-
tors are not readily amenable to change.
Medicine has done its job well in finding
new avenues of treatment and detection.
However, the existence ofa cure without a
cause continues because no pathways for
prevention have been found. Innovative
research should be undertaken to develop
better methods and to elucidate potential
mechanisms for environmental exposures
and breast cancer.
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